As of 1:32 PM on the 28th, Celltrion is trading at 341,500 KRW, down 1.73% from the previous day. This represents a 15.37% decrease compared to December 7. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have a net purchase of 85,143 shares of Celltrion, and institutions have a net purchase of 27,000 shares, according to preliminary data. Over the past five days, individual investors have net sold 524,520 shares, while foreigners and institutions have net bought 271,545 shares and 259,060 shares, respectively.


On December 20, Celltrion made headlines in the market with the issue titled "Global '7 trillion KRW' market capture... Global autoimmune disease treatment..."


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing